Refractory adult-onset Still disease complicated by macrophage activation syndrome and acute myocarditis: A case report treated with high doses (8mg/kg/d) of anakinra

التفاصيل البيبلوغرافية
العنوان: Refractory adult-onset Still disease complicated by macrophage activation syndrome and acute myocarditis: A case report treated with high doses (8mg/kg/d) of anakinra
المؤلفون: Elisa Gremese, Gianfranco Ferraccioli, F. Parisi, Annamaria Paglionico, Valentina Varriano
بيانات النشر: Lippincott Williams and Wilkins, 2017.
سنة النشر: 2017
مصطلحات موضوعية: 0301 basic medicine, Adult, Adult-Onset, medicine.medical_specialty, Myocarditis, Settore MED/16 - REUMATOLOGIA, adult-onset Still disease, anakinra, macrophage activation syndrome, myiocarditis, Antirheumatic Agents, Drug Resistance, Female, Humans, Interleukin 1 Receptor Antagonist Protein, Macrophage Activation Syndrome, Still's Disease, Adult-Onset, Medicine (all), Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Refractory, Internal medicine, medicine, Coagulopathy, 030203 arthritis & rheumatology, Anakinra, business.industry, General Medicine, medicine.disease, Rash, Still's Disease, 030104 developmental biology, Macrophage activation syndrome, Heart failure, medicine.symptom, Complication, business, medicine.drug
الوصف: RATIONALE Myocarditis is a rare but potentially fatal complication of Still's disease (about 7% of total cases). PATIENT CONCERNS A 42-year-old woman was admitted to our ward with high-grade fever, rash and polyarthralgia, lasting since 4 weeks and rapidly complicated by MAS and acute heart failure. DIAGNOSES Adult Onset Still's Disease rapidly developping macrophage activation syndrome and disseminated intravascular coagulopathy, further complicated by iperacute myocarditis with cardiac arrest. INTERVENTIONS After failure of conventional therapies (steroids plus cyclosporine and then biological therapy with Anakinra 100 mg/day), the patient was treated with anakinra 100 mg sc 1 fl 4 times a day. OUTCOMES Fast clinical and laboratoristic improvement and subsequent disease remission with complete recovery of cardiac function. LESSONS This is the first case report in which high doses of Anakinra have been used to treat a refractory AOSD complicated by MAS and myocarditis. In AOSD complicated by life-threatening conditions, probably we need to consider aggressive therapeutic approaches with higher doses of Il-1 receptor blocker to switch off the hyper-inflammation.
اللغة: English
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07b2fee1214b6ed475a1239bc317e67fTest
http://hdl.handle.net/10807/122673Test
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....07b2fee1214b6ed475a1239bc317e67f
قاعدة البيانات: OpenAIRE